Screening Criteria Evaluation for Expansion in Pulmonary Neoplasias (SCREEN).

The SCREEN study investigated screening eligibility and survival outcomes between heavy smokers and light-or-never-smokers with lung cancer to determine whether expanded risk factor analysis is needed to refine screening criteria. SCREEN is a retrospective study of 917 lung cancer patients diagnosed between 2005 and 2018 in Nova Scotia, Canada. Screening eligibility was determined using the National Lung Screening Trial (NSLT) criteria. Mortality risk between heavy smokers and light-or-never-smokers was compared using proportional-hazards models. The median follow-up was 2.9 years. The cohort was comprised of 179 (46.1%) female heavy smokers and 306 (57.8%) female light-or-never-smokers. Light-or-never-smokers were more likely to have a diagnosis of adenocarcinoma [n=378 (71.6%)] compared to heavy smokers [n=234 (60.5%); P< 0.001]. Heavy smokers were more frequently diagnosed with squamous cell carcinoma [n=111 (28.7%)] compared to light-or-never-smokers, [n=100 (18.9%); P< 0.001]. Overall, 36.9% (338) of patients met NLST screening criteria. There was no difference in 5-year survival between light-or-never-smokers and heavy smokers [55.2% (338) vs 58.5% (529); P = 0.408; HR 1.06, 95% CI 0.80-1.40; P = 0.704]. Multivariate analysis showed that males had an increased mortality risk [HR 2.00 (95% CI 1.57-2.54); P< 0.001]. Half of lung cancer patients were missed with the conventional screening criteria. There were more curable, stage 1 tumors among light-or-never-smokers. Smoking status and age alone may be insufficient predictors of lung cancer risk and prognosis. Expanded risk factor analysis is needed to refine lung cancer screening criteria.

A practical guide to diagnosis, management and treatment of testosterone deficiency for Canadian physicians.

The percentage of men receiving appropriate management for testosterone deficiency syndrome (TDS) is small in comparison to prevalence estimates. This is despite linkages to cardiovascular disease, osteoporosis, diabetes, sexual function, sarcopenia, emotional well-being and the metabolic syndrome. Furthermore, the availability of guidelines has not significantly enhanced the care of TDS patients. A multidisciplinary group of medical experts sought to improve the management of testosterone-deficient patients by Canadian physicians. This report describes their conclusions and defines an algorithm for appropriate TDS management.

Predicting urinary stone composition using X-ray coherent scatter: a novel technique with potential clinical applications.

PURPOSE: Coherent scatter properties depend on the molecular structure of the scattering medium and measured scatter patterns are often characteristic of a chemical species. We explored the usefulness of coherent scatter analysis as a basis for identifying urinary calculus composition. MATERIALS AND METHODS: A laboratory system for collecting coherent scatter signals from biological specimens was developed. This technique uses a diagnostic x-ray tube and image intensifier, and measures coherent scatter from intact renal stones. The coherent scatter signatures of 6 common stone components (calcium oxalate monohydrate, calcium phosphate, calcium phosphate dihydrate, cystine, magnesium ammonium phosphate and uric acid) were acquired from pure chemical samples and stones identified by infrared spectroscopy as having a uniform composition. In addition, a sample of calculus identified as containing only calcium oxalate dihydrate was examined. The same fragmented stone samples analyzed by infrared spectroscopy were scanned using coherent scatter. RESULTS: In each case the scatter patterns from powdered chemicals and fragmented stones showed circular symmetry and consisted of a series of broad rings of various intensities. Each pure chemical sample produced a distinct coherent scatter pattern. The signatures of the stone specimens closely agreed with those of the chemical samples. CONCLUSIONS: These initial results indicate that coherent scatter analysis using diagnostic x-rays has potential as a tool for urinary calculous composition identification. Further developments in this technique may have the potential for determining the composition of a calculus in vivo before therapy, thus, aiding in therapy planning.